Senate Committee of Reference Report
Committee on Appropriations
- Strikethrough:
- removed from existing law
- Screen Reader Only:
- all text indicated as strikethrough will begin as 'deleted from existing statue' and finish with 'end deletion'
- All-caps or Bold and Italic:
- added to existing law
- Screen Reader Only:
- all text indicated as all-caps or bold and italic will begin as 'added to existing law' and finish with 'end insertion'
April 29, 2025
After consideration on the merits, the Committee recommends the following:
SB25-048 be amended as follows, and as so amended, be referred to the Committee of the Whole with favorable recommendation:
Page 1, Line 1Amend printed bill, page 3, strike lines 14 through 16 and substitute
Page 1, Line 2"youth should include anti-obesity medications and that this treatment
Page 1, Line 3option is safe and effective. Eight out of ten adolescents with".
Page 1, Line 4Page 3, strike lines 21 through 27.
Page 1, Line 5Strike pages 4 through 9.
Page 1, Line 6Page 10, strike lines 1 through 12 and substitute:
Page 1, Line 7"SECTION 3. In Colorado Revised Statutes, 10-16-104, add (29)
Page 1, Line 8as follows:
Page 1, Line 910-16-104. Mandatory coverage provisions - applicability -
Page 1, Line 10rules - definitions. (29) Treatment for obesity and pre-diabetes.
Page 1, Line 11(a) All individual and group health plans issued or renewed in
Page 1, Line 12this state must provide coverage for the treatment of the
Page 1, Line 13chronic disease of obesity and the treatment of pre-diabetes,
Page 1, Line 14including coverage for the national diabetes prevention
Page 1, Line 15program, medical nutrition therapy, intensive behavioral or
Page 1, Line 16lifestyle therapy, and metabolic and bariatric surgery.
Page 1, Line 17(b) For a large group health benefit plan offered in this
Page 1, Line 18state, a carrier shall offer the policyholder the option to
Page 1, Line 19purchase coverage for FDA-approved anti-obesity medications,
Page 1, Line 20including at least one FDA-approved GLP-1 medication. This
Page 1, Line 21subsection (29) does not require a carrier to offer coverage for
Page 1, Line 22which premiums would not cover expected benefits.
Page 1, Line 23(c) The commissioner may adopt rules to implement this
Page 1, Line 24subsection (29).
Page 1, Line 25(d) As used in this subsection (29):
Page 2, Line 1(I) "FDA-approved anti-obesity medication" means a
Page 2, Line 2medication approved by the federal food and drug
Page 2, Line 3administration with an indication for weight management in
Page 2, Line 4patients with chronic obesity.
Page 2, Line 5(II) "FDA-approved GLP-1 medication" means a
Page 2, Line 6glucagon-like peptide-1 receptor agonist that is approved by the
Page 2, Line 7federal food and drug administration with an indication for
Page 2, Line 8regulating blood sugar levels and appetite.
Page 2, Line 9(III) "Intensive behavioral or lifestyle therapy" means an
Page 2, Line 10evidence-based, multi-component behavioral or lifestyle
Page 2, Line 11modification intervention designed to support healthy weight
Page 2, Line 12management as recommended by current clinical standards of
Page 2, Line 13care. Interventions include obesity screening, dietary
Page 2, Line 14assessment, and behavioral counseling and therapy aimed at
Page 2, Line 15weight loss through lifestyle modifications such as changes in
Page 2, Line 16diet and increased physical activity. Therapy for obesity must be
Page 2, Line 17consistent with the United States Preventive Services Task
Page 2, Line 18Force's 5-A behavioral counseling framework: Ask, advise,
Page 2, Line 19assess, assist, and arrange. Interventions may be provided
Page 2, Line 20in-office, virtually through telehealth, or in community-based
Page 2, Line 21settings to support patient access and needs.
Page 2, Line 22(IV) "Medical nutrition therapy" means the following
Page 2, Line 23nutrition care services that prevent, manage, or treat diseases
Page 2, Line 24or medical conditions, which services may be provided in-office
Page 2, Line 25or virtually through telehealth:
Page 2, Line 26(A) Nutrition assessment;
Page 2, Line 27(B) Nutrition diagnosis;
Page 2, Line 28(C) Nutrition intervention; and
Page 2, Line 29(D) Nutrition monitoring and evaluation.
Page 2, Line 30(V) "Metabolic and bariatric surgery" means metabolic
Page 2, Line 31and bariatric surgery recommended according to the guidelines
Page 2, Line 32published in the 2022 American Society for Metabolic and
Page 2, Line 33Bariatric Surgery and International Federation for the
Page 2, Line 34Surgery of Obesity and Metabolic Disorders: Indications for
Page 2, Line 35Metabolic and Bariatric Surgery.
Page 2, Line 36(VI) "National diabetes prevention program" means a
Page 2, Line 37structured, evidence-based lifestyle modification program
Page 2, Line 38designed to prevent or delay the onset of diabetes in individuals
Page 2, Line 39at high risk in accordance with 42 U.S.C. sec. 280g-14. The
Page 2, Line 40program follows a standardized curriculum and is focused on
Page 2, Line 41promoting healthy lifestyle changes, including weight loss,
Page 2, Line 42increased physical activity, and healthier eating habits,
Page 2, Line 43through individual and group intervention.
Page 3, Line 1SECTION 4. In Colorado Revised Statutes, 25.5-8-107, add
Page 3, Line 2(1)(a)(V) as follows:
Page 3, Line 325.5-8-107. Duties of the department - schedule of services -
Page 3, Line 4premiums - copayments - subsidies - purchase of childhood
Page 3, Line 5immunizations. (1) In addition to any other duties pursuant to this article
Page 3, Line 68, the department has the following duties:
Page 3, Line 7(a) (IV) The schedule of health-care services included in
Page 3, Line 8the plan must not include coverage pursuant to the mandatory
Page 3, Line 9coverage provisions of section 10-16-104 (29).".
Page 3, Line 10Renumber succeeding section accordingly.